NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (OTCQB:QTIH) a medical device company engaged in research, development, and commercialization of innovative body imaging systems is pleased to announce today shipment of six QTI Breast Acoustic CT™ Systems for total revenue of $2.7 million, as previously projected by the Company.
“We are excited to announce the shipment of six QT Breast Acoustic CT™ Systems, a significant milestone in our plan to deliver in accordance with our projections for the first quarter of 2025. This achievement highlights the strength of our strategic partnership with NXC Imaging, Inc. and our continued commitment to providing innovative solutions for the breast imaging market. We look forward to further advancing our product offerings and expanding our reach in the medical imaging industry,” said Steve Choate, Chief Operations Officer of the Company.
Ad Statistics
Times Displayed: 26180
Times Visited: 582 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
About QT Imaging Holdings, Inc.
QT Imaging Holdings, Inc. is a public (OTCQB: QTIH) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging Holdings, Inc., please visit the company’s website at www.qtimaging.com.
